Apis Mellifera Aralia Racemosa Root Arundo Plinian
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- Apis Mellifera Aralia Racemosa Root Arundo Plinian
- 14-Component Homeopathic Formula (Apis/Echinacea/Histamine + 11): Original Indication Unknown — TxGNN Prediction Unavailable
14-Component Homeopathic Formula (Apis/Echinacea/Histamine + 11): Original Indication Unknown — TxGNN Prediction Unavailable
One-Sentence Summary
This entry describes a complex 14-ingredient homeopathic botanical combination — including Apis mellifera (bee venom), Echinacea, Histamine dihydrochloride, Euphrasia stricta, and Urtica urens — whose ingredient profile is broadly consistent with allergy and upper respiratory immune-support formulations. However, TxGNN returned no predicted new indications for this entry, most likely because the multi-component formula could not be resolved to a single DrugBank ID. Without a prediction or matched regulatory record, this candidate cannot be evaluated under the standard repurposing framework at this time.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not recorded |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — Model prediction unavailable |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |
About This Formula
Although the full ingredient string was submitted to TxGNN and DrugBank, no DrugBank ID was successfully assigned to the combination as a whole. The 14 active ingredients are:
| # | Ingredient | Common Homeopathic Use |
|---|---|---|
| 1 | Apis mellifera (bee venom) | Inflammatory swelling, urticaria |
| 2 | Aralia racemosa root | Upper respiratory, asthma |
| 3 | Arundo pliniana root | Allergic rhinitis, hay fever |
| 4 | Baptisia tinctoria root | Systemic infection, flu |
| 5 | Echinacea (unspecified) | Immune stimulation, cold/flu |
| 6 | Euphrasia stricta | Eye irritation, hay fever |
| 7 | Gelsemium sempervirens root | Flu-like states, anxiety |
| 8 | Histamine dihydrochloride | Isopathic allergy desensitisation |
| 9 | Lycopodium clavatum spore | Respiratory, digestive complaints |
| 10 | Onion (Allium cepa) | Hay fever, coryza |
| 11 | Sanguinaria canadensis root | Rhinitis, sinusitis |
| 12 | Schoenocaulon officinale seed (Sabadilla) | Allergic rhinitis, sneezing |
| 13 | Toxicodendron pubescens leaf (Rhus tox) | Joint pain, skin eruptions |
| 14 | Urtica urens whole | Urticaria, allergic pruritus |
The ingredient cluster — Apis mellifera, Arundo, Euphrasia, Histamine dihydrochloride, Allium cepa (Onion), Sabadilla, and Urtica urens — is a well-recognised constellation used in commercial homeopathic allergy products. The formula is likely a branded product targeting allergic rhinitis, hay fever, or upper respiratory hypersensitivity, but the specific brand name was not recoverable from the query data.
Safety Considerations
Please refer to the package insert for safety information. No DDI data, warnings, or contraindications were returned by the automated queries.
Conclusion and Next Steps
Decision: Hold
Rationale: TxGNN could not generate any repurposing predictions because the 14-ingredient formula could not be matched to a unified DrugBank entry. Without a prediction, the standard evidence evaluation pipeline (clinical trials, literature, mechanism analysis) cannot be executed for this candidate as a whole.
To proceed, the following is needed:
- Identify the brand name: Cross-reference the ingredient list against known homeopathic allergy products (e.g., Heel BHI Allergy, Rhinallergy, or similar) to recover the registered product identity
- Obtain the approved indication: Retrieve the original indication from the product’s package insert or its originating country’s regulatory filing
- Resolve a DrugBank ID: Either map the brand product to an existing DrugBank composite entry, or select one or two pharmacologically dominant ingredients (e.g., Histamine dihydrochloride, Echinacea) to run as independent TxGNN queries
- Re-run TxGNN per active ingredient: Breaking out key ingredients individually (particularly Histamine dihydrochloride and Echinacea) may yield actionable predictions that can be aggregated
- Retrieve safety data: Download the product’s package insert PDF and extract warnings and contraindications to clear DG001
- Clarify regulatory scope: Confirm whether any single-ingredient version (e.g., Echinacea extract) is already marketed in the target jurisdiction, as this would open a faster regulatory pathway
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.